InvestorsHub Logo
Followers 58
Posts 6495
Boards Moderated 0
Alias Born 03/25/2015

Re: JPetroInc post# 126209

Thursday, 04/06/2017 3:42:49 PM

Thursday, April 06, 2017 3:42:49 PM

Post# of 130513
Quote:"Following SeD Biomedical's preliminary due diligence, SeD Biomedical has informed Amarantus' management of strategic measures that must be met by creditors and certain other parties as a condition for any investment, loan or asset injection by SeD Biomedical."

Apparently they found what they could.Did they know that GC was advisor to Intl infusion at the same time?.